The group’s goal is to develop value of best projects with potential for global market expansion in the areas of: cancer prevention, early diagnostics, targeted cancer therapies ,oncological rehabilitation, human blood substitutes
Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups:
The software processes in real-time images obtained with standard medical devices (CT, X-Ray, MRI) into a 3D model of the patient's anatomy allowing mutual positioning of the patient and medical instruments in the operating field. The 3D model is displayed on the screen placed over the patient's body, and ultimately on the glasses for augmented reality.
